Author
Listed:
- Yan Zhang
(University of Texas Health Science Center at Houston
Huazhong University of Science and Technology)
- Dayong Zheng
(University of Texas Health Science Center at Houston
Southern Medical University)
- Ting Zhou
(University of Texas Health Science Center at Houston
Southern Medical University)
- Haiping Song
(University of Texas Health Science Center at Houston
Huazhong University of Science and Technology)
- Mohit Hulsurkar
(University of Texas Health Science Center at Houston
University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences)
- Ning Su
(University of Texas Health Science Center at Houston
Guangzhou Chest Hospital)
- Ying Liu
(University of Texas Health Science Center at Houston
Central South University)
- Zheng Wang
(University of Texas Health Science Center at Houston)
- Long Shao
(Baylor College of Medicine, and Michael E. DeBakey VAMC)
- Michael Ittmann
(Baylor College of Medicine, and Michael E. DeBakey VAMC)
- Martin Gleave
(University of British Columbia)
- Huanxing Han
(Changzheng Hospital)
- Feng Xu
(Southern Medical University)
- Wangjun Liao
(Southern Medical University)
- Hongbo Wang
(Huazhong University of Science and Technology)
- Wenliang Li
(University of Texas Health Science Center at Houston
University of Texas Health Science Center at Houston
University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences)
Abstract
The incidence of aggressive neuroendocrine prostate cancers (NEPC) related to androgen-deprivation therapy (ADT) is rising. NEPC is still poorly understood, such as its neuroendocrine differentiation (NED) and angiogenic phenotypes. Here we reveal that NED and angiogenesis are molecularly connected through EZH2 (enhancer of zeste homolog 2). NED and angiogenesis are both regulated by ADT-activated CREB (cAMP response element-binding protein) that in turn enhances EZH2 activity. We also uncover anti-angiogenic factor TSP1 (thrombospondin-1, THBS1) as a direct target of EZH2 epigenetic repression. TSP1 is downregulated in advanced prostate cancer patient samples and negatively correlates with NE markers and EZH2. Furthermore, castration activates the CREB/EZH2 axis, concordantly affecting TSP1, angiogenesis and NE phenotypes in tumor xenografts. Notably, repressing CREB inhibits the CREB/EZH2 axis, tumor growth, NED, and angiogenesis in vivo. Taken together, we elucidate a new critical pathway, consisting of CREB/EZH2/TSP1, underlying ADT-enhanced NED and angiogenesis during prostate cancer progression.
Suggested Citation
Yan Zhang & Dayong Zheng & Ting Zhou & Haiping Song & Mohit Hulsurkar & Ning Su & Ying Liu & Zheng Wang & Long Shao & Michael Ittmann & Martin Gleave & Huanxing Han & Feng Xu & Wangjun Liao & Hongbo W, 2018.
"Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers,"
Nature Communications, Nature, vol. 9(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06177-2
DOI: 10.1038/s41467-018-06177-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06177-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.